Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Case report: silent thyroiditis developed during alpha-interferon therapy

K Kamikubo1, R Takami, T Suwa

  • 1Department of Internal Medicine, Takayama Red Cross Hospital, Japan.

The American Journal of the Medical Sciences
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The interplay between thiol-compounds against chromium (VI) in the freshwater green alga Monoraphidium convolutum: toxicology, photosynthesis, and oxidative stress at a glance.

Aquatic toxicology (Amsterdam, Netherlands)·2012
Same author

An incidentally discovered small and asymptomatic para-aortic paraganglioma.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes·2007
Same author

Nutritional status of people living in Dzong village, in the northern mountainous area of Nepal.

Asia-Pacific journal of public health·2006
Same author

Varied presentations of pseudoxanthoma elasticum in a family.

Journal of paediatrics and child health·2006
Same author

7-12 Hz cortical oscillations: behavioral context and dynamics of prefrontal neuronal ensembles.

Neuroscience·2005
Same author

Biodiversity of Lactobacillus sanfranciscensis strains isolated from five sourdoughs.

Letters in applied microbiology·2005
Same journal

Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

The American journal of the medical sciences·2026
Same journal

In Memoriam: Maurice A. Mufson, MD, MACP.

The American journal of the medical sciences·2026
Same journal

Outcomes of acute myeloid leukemia patients admitted to the intensive care unit within 100 days of allogeneic hematopoietic stem cell transplantation.

The American journal of the medical sciences·2026
Same journal

Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

The American journal of the medical sciences·2026
Same journal

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same journal

The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

The American journal of the medical sciences·2026
See all related articles

Alpha-interferon (IFN-alpha) therapy for hepatitis C can trigger thyrotoxicosis in patients with pre-existing thyroiditis. Monitoring thyroid function and antibodies before and during treatment is recommended.

Area of Science:

  • Immunology
  • Endocrinology
  • Hepatology

Background:

  • Chronic active hepatitis C treatment often involves alpha-interferon (IFN-alpha).
  • Patients may have underlying autoimmune conditions, including thyroid disorders.

Observation:

  • A euthyroid woman with low antithyroid antibodies developed thyrotoxicosis during IFN-alpha therapy.
  • Thyroid function tests showed elevated free thyroid hormones, suppressed thyrotropin, increased antimicrosomal antibodies, and reduced thyroid uptake.

Findings:

  • IFN-alpha therapy likely exacerbated a pre-existing chronic thyroiditis, leading to silent thyroiditis.
  • Thyroid dysfunction resolved after completing IFN-alpha treatment.

Implications:

  • Pretreatment screening for antithyroid antibodies and thyroid function is crucial for patients receiving IFN-alpha.

Related Experiment Videos

  • Early detection and monitoring can prevent severe thyroid dysfunction during IFN-alpha therapy.